No Data
No Data
Ubiquiti, Red Robin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Cronos Rises 4% After Crypto.com Announces Partnership With UEFA Champions League
Canopy Growth Posts Wider-than-expected Loss as Revenue Falls, but Company Sees Growth Opportunities in U.S. Markets
Express News | Cronos Group Inc : BofA Global Research Cuts Price Objective to $2.30 From $2.75
Cronos Group: Caution Advised Amid Regulatory Uncertainties and Sector Re-rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cronos Group (CRON), Relay Therapeutics (RLAY) and Century Therapeutics (IPSC)